We are laying the foundations for personalized therapies by developing strategies for novel immunotherapeutic approaches or clinically relevant biomarkers.
Joining forces against cancer
As an outcome of a longstanding collaboration with the Helmholtz Centre for Heavy Ion Research, promising results for the treatment of radioresistant tumors have been published.
Read more
curATalk seminar series
We are looking forward to our next speaker within the curATime seminar series, Dr. Laura Bindila from the University Medical Center Mainz, Germany. We invite everyone to join her seminar about "Modern lipidomics approaches for clinical and preclinical research and profiling" on April 18th, at 5 pm.
Read more
Los geht’s - Symbolischer Spatenstich für unseren Neubau
Am 09.04.2024 hat der symbolische Spatenstich für unseren Neubau in der Mainzer Oberstadt stattgefunden. Das Labor- und Bürogebäude soll 2027 einzugsbereit sein.
Read more
TRON is participating in the curious 2024 Future Insight Conference in Mainz
We are delighted to announce our sponsorship of the Curious2024 Future Insights conference organized by the Future Insight e.V.
Read more
First curATime Hackathon “curAHack” in April
curAHack is an open hackathon event for young scientists, bioinformaticians and healthcare-enthusiasts to tackle research challenges adressed within the curATime cluster. Join us on April 08th -9th, 2024 at the Gutenberg Digital Hub in Mainz!
Read more
curAEquality Award 2024
At the first curAMeet conference last week, Romina Wolz from the University Medical Center Mainz received the curAEquality Award 2024 for her outstandingly Gender and Diversity inclusive research in her curATime subproject "Role of macrophage coagulation signaling in atherosclerosis".
Read more
curAMeet 2024
During our first curATime conference, the curAMeet 2024, we are going to bring the whole curATime network together for the first time. We are looking forward to learning about the recent findings in cardiovascular research and to listening to e.g. experts in the field of atherothrombosis, mRNAand AI at our venue in Mainz.
Read more
curATalk seminar series
We are looking forward to our next curATalk by Prof Stefan Engelhard, the speaker of the CNATM Cluster (Cluster for Nucleic Acid Therapeutics Munich). Prof Engelhard will talk about "Macrophage-targeted RNA therapeutics" on January 15th, at 5 pm.
Read more
Seminars in Translational Oncology
On December 5th 2023, Dr. Mark Schmitt from the Institute of Pharmacology at the University of Marburg will visit us at TRON. During his stay, he will talk about “Cellular plasticity in intestinal inflammation and tumorigenesis”.
Read more
curATalk Christoph Reinhardt
Our next speaker within the curATime seminar series is Junior Prof Dr Christoph Reinhardt from the University Medical Center Mainz, Germany. Everyone who likes to take part can join his seminar about "Microbiota and Arterial Thrombosis" on November 08th, at 5 pm.
Read more
Unser neuer Kaufmännischer Geschäftsführer
Mit Wirkung zum 1. Oktober 2023 wurde Dr. Michael Ludorf zum neuen Kaufmännischen Geschäftsführer bestellt und übernimmt sämtliche Aufgaben im Bereich der Administration der TRON gGmbH.
Read more
Seminars in Translational Oncology
During his visit, PD Dr. Robert Zweigerdt from Hannover Medical School will give us insights about his research on “Making and Repairing Hearts with human Pluripotent Stem Cells”.
Read more
Mainzer Firmenlauf 2023 - Wir waren mit dabei!
Beim diesjährigen 5 km Firmenlauf waren wir mit unglaublichen 22 TRON-Läufern vertreten - das ist ein neuer Rekord! Bei bestem Wetter und mit Proteinriegeln gestärkt hatten wir sehr viel Spaß bei dem Event in der Stadt unserer Herzen.
Read more
Application for our joint international PhD program: ATLAS - Talent Academy for TransLAtional Science is now open
ATLAS, the joint PhD program between TRON and BioNTech provides a unique chance for young researchers to pursue their scientific career in the field of translational science. The call is now open for application until October 31st, 2023.
Read more
Seminars in Translational Oncology
Profs Carlos Fernandez-Hernando and Andres Hidalgo from the Yale School of Medicine visit us in Mainz and we are pleased to invite you to two immunology talks about their exciting work.
Read more
TRON unterstützt den Mainzer Wissenschaftsmarkt
Als langjähriges Mitglied der Mainzer Wissenschaftsallianz freuen wir uns auf den 21. MAINZER WISSENSCHAFTSMARKT am 09. und 10. September 2023 in der Mainzer Innenstadt!
Read more
curATalk seminar series
Our next speaker within the curATime seminar series is Dr Muhammad Nabeel Asim from the German Research Center for Artificial Intelligence (DFKI) in Kaiserslautern.Everyone who is interested is welcome to join his talk "Protein Protein interaction prediction in our AI based Genomics and Proteomics Sequence Analysis Framework" on Aug 08th, at 5 pm.
Read more
Schülerinnen im Rahmen der SommerUni zu Gast am TRON
In der Woche vom 24.-28.07.2023 konnten Schülerinnen der gymnasialen Oberstufe bei uns im Haus erste Laborluft schnuppern.
Read more
TRON employees give their best at the “Rudern gegen Krebs” event in Mainz
To make a statement against cancer, our five rowing teams did a great job by taking part in the charity race "Rudern gegen Krebs" on the Rhine in Mainz on July 16th 2023.
Read more
Seminar in Translational Oncology
We are happy to welcome Prof. Dr. Laura D. Wood from the Sol Goldman Pancreatic Cancer Research Center at the Johns Hopkins University School of Medicine, MD, USA. Next to meeting various scientists, she will be giving a seminar on "Genomic and Spatial Analyses of Human Precancerous Pancreatic Neoplasms".
Read more
TRON enters into a cooperation with Green Elephant
Sustainable research is an important topic for us. Therefore, we entered into a cooperation with Green Elephant Biotech, a start up that develops sustainable, plant-based cell culture expansion systems.
Read more
curATalk Seminar Series
Our next speaker within the curATime seminar series is Prof Dr Klaus Ley from the Immunology Center of Georgia, Augusta University, USA. Everyone who is interested is welcome to join his talk "Breaking Tolerance: The Autoimmune Aspect of Atherosclerosis" on June 12th, at 5 pm.
Read more
Der SFB1399 geht in die 2. Förderperiode
Der Sonderforschungsbereich “Mechanisms of Drug Sensitivity and Resistance in Small Cell Lung Cancer (SFB1399)" geht in die zweite Runde. Die deutsche Forschungsgemeinschaft (DFG) entschied, dass das von der Universität Köln im Jahr 2019 initiierte Projekt die Förderung für weitere vier Jahre erhält.
Read more
Laborkittel bekommen eine zweite Chance
Wir denken aktiv darüber nach, wie wir Abfälle reduzieren und nachhaltiger arbeiten können. Deshalb haben sich in einem ersten Schritt Labormitglieder zusammengetan, um unsere ältere Generation von Laborkitteln zu recyceln. Diese wurden jetzt dem Gutenberg-Gymnasium in Mainz und der Fachschaft der Johannes Gutenberg-Universität Mainz zur Verfügung gestellt, damit sie weiterhin ihre Aufgabe erfüllen können.
Read more
curATalk seminar series
Our next speaker within the curATime seminar series is Dr. Johnny Kim who recently joined us at TRON to accelerate the implementation of our new research focus on cardiovascular diseases.
Read more